Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

03 June 2004

Endogenous morphine: A role in wellness medicine

George B. Stefano

Med Sci Monit 2004; 10(6): ED5-5 :: ID: 16400

Abstract

The demonstration of the multiplicity of opiate receptor types has led to the understanding that,
depending on their site of action, opioid peptides as well as opiate alkaloids may bind to more than one opiate receptor subtype. In addition to the two main µ opiate receptor subtypes, µ1 and µ2, our laboratory has demonstrated a third µ opiate receptor (µ3) that is selective for opiate alkaloids but insensitive to opioid peptides. Recently, the µ3 opiate receptor subtype has been cloned from human immune, vascular and neural tissues. This µ3 story complements many biochemical reports; demonstrating morphine is an endogenous signaling molecule, functioning in the
capacity of a neurotransmitter and hormone. Adding additional evidence to this hypothesis are the fi ndings of morphine precursors in mammalian and invertebrate tissues. The reports published in this issue of MSM complement this story while advancing the hypothesis by placing opiate alkaloid signaling in limbic structures. The pharmacological characteristics of exogenous morphine fi nd a role for explaining morphine action in an “emotional” and belief setting. Within this context, multiple component expectation-induced placebo effects may involve morphinergic signaling, since a reduction of placebo effects by the opioid selective antagonist naloxone has been demonstrated. Neurons immunoreactive for morphine are largely present all along the extension of PAG and in brainstem raphe nuclei. This process also may be active in altering the experience of pain. Moreover, the prefrontal cortex possesses close neural connections to limbic
components such as the hippocampal formation and cingulate cortex where morphine immunoreactivity
is largely present in neurons and fi bers. These limbic areas play a major role in memory
processes and also mediate motivational, affective and autonomic responses often accompanying
pain. Additionally, endogenous morphine appears to modulate memory processes playing a role in weakening the memory of a nociceptive experience. Limbic areas also are connected to the prefrontal cortex, which integrates emotion, memory, belief, expectation, motivation and reward processing, i.e, affective and motivational responses. Taken together, prefrontal cortex activation in placebo as well as complementary medical techniques (CMT) may refl ect a form of externally elicited top-down CNS control, possibly involving morphinergic pathways. Common brain structures like frontal and limbic regions get activated in various CMT approaches, indicating a crucial role of affect and belief. CMT therapies also possess a stress-reducing capacity that may be addressed in self-care-oriented medical procedures, some of them accepted for their low-cost (although effective) way of acting in the healing process given their down regulating properties. While medical knowledge and technical abilities are expanding, they still have to be affordable. CMT may help to solve this problem. Thus, the existence of subjective CNS phenomena and commonalities in CMT may emphasize the signifi cance of naturally occurring health processes
and general self-care capabilities. Trust and belief may increasingly become part of future therapeutic
strategies and regular medicine.

Keywords: Brain - metabolism, Health, Medicine, Morphine - metabolism, Receptors, Opioid - metabolism, Brain - metabolism, Health, Medicine, Morphine - metabolism, Receptors, Opioid - metabolism

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

26 Feb 2024 : Clinical Research  

Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...

Med Sci Monit In Press; DOI: 10.12659/MSM.942509  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750